DK2513056T3 - Kemiske reagenser til aktivering af polysaccharider i fremstillingen af konjugatvacciner - Google Patents
Kemiske reagenser til aktivering af polysaccharider i fremstillingen af konjugatvacciner Download PDFInfo
- Publication number
- DK2513056T3 DK2513056T3 DK10842660.2T DK10842660T DK2513056T3 DK 2513056 T3 DK2513056 T3 DK 2513056T3 DK 10842660 T DK10842660 T DK 10842660T DK 2513056 T3 DK2513056 T3 DK 2513056T3
- Authority
- DK
- Denmark
- Prior art keywords
- polysaccharides
- activation
- manufacture
- chemical reagents
- conjugate vaccines
- Prior art date
Links
- 108010060123 Conjugate Vaccines Proteins 0.000 title 1
- 230000004913 activation Effects 0.000 title 1
- 239000003153 chemical reaction reagent Substances 0.000 title 1
- 229940031670 conjugate vaccine Drugs 0.000 title 1
- 150000004676 glycans Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 229920001282 polysaccharide Polymers 0.000 title 1
- 239000005017 polysaccharide Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
- C07K17/10—Peptides being immobilised on, or in, an organic carrier the carrier being a carbohydrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
- C08H1/00—Macromolecular products derived from proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28759309P | 2009-12-17 | 2009-12-17 | |
PCT/US2010/061133 WO2011084705A2 (en) | 2009-12-17 | 2010-12-17 | Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2513056T3 true DK2513056T3 (da) | 2022-05-23 |
Family
ID=44306072
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK10842660.2T DK2513056T3 (da) | 2009-12-17 | 2010-12-17 | Kemiske reagenser til aktivering af polysaccharider i fremstillingen af konjugatvacciner |
Country Status (13)
Country | Link |
---|---|
US (4) | US9044517B2 (da) |
EP (1) | EP2513056B1 (da) |
JP (4) | JP5892944B2 (da) |
KR (4) | KR101635795B1 (da) |
CN (1) | CN102892753B (da) |
BR (4) | BR122022002139B1 (da) |
CA (4) | CA2836140C (da) |
DK (1) | DK2513056T3 (da) |
ES (1) | ES2913180T3 (da) |
MX (1) | MX2012006961A (da) |
SG (4) | SG10201506165TA (da) |
WO (1) | WO2011084705A2 (da) |
ZA (1) | ZA201204279B (da) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011084705A2 (en) * | 2009-12-17 | 2011-07-14 | Fina Biosolutions, Llc | Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines |
EP2809349B1 (en) * | 2012-01-30 | 2018-12-19 | Serum Institute Of India Private Limited | Immunogenic composition |
CN103690944A (zh) * | 2013-12-27 | 2014-04-02 | 中国科学院过程工程研究所 | 一种脑膜炎多糖结合疫苗及其制备方法 |
EP2921856B1 (en) * | 2014-03-18 | 2016-09-14 | Serum Institute Of India Private Limited | A quantitative assay for 4-pyrrolidinopyridine (4-ppy) in polysaccharide-protein conjugate vaccines |
US11246918B2 (en) | 2017-02-03 | 2022-02-15 | Eva Barbara Schadeck | Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof |
JOP20200214A1 (ar) * | 2019-09-03 | 2021-03-03 | Serum Institute Of India Pvt Ltd | تركيبات مولدة للمناعة ضد الأمراض المعوية وطرق لتحضيرها |
WO2021174330A1 (en) * | 2020-03-05 | 2021-09-10 | Nuecology Biomedical Inc. | Amphiphilic alginate-oleic acid macromolecules and process for preparation therof |
Family Cites Families (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4356170A (en) | 1981-05-27 | 1982-10-26 | Canadian Patents & Development Ltd. | Immunogenic polysaccharide-protein conjugates |
US5360897A (en) | 1981-08-31 | 1994-11-01 | The University Of Rochester | Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad |
US4496538A (en) * | 1982-07-06 | 1985-01-29 | Connaught Laboratories, Inc. | Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine |
US4663160A (en) | 1983-03-14 | 1987-05-05 | Miles Laboratories, Inc. | Vaccines for gram-negative bacteria |
US4540573A (en) | 1983-07-14 | 1985-09-10 | New York Blood Center, Inc. | Undenatured virus-free biologically active protein derivatives |
US4695624A (en) | 1984-05-10 | 1987-09-22 | Merck & Co., Inc. | Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency |
US4678553A (en) | 1986-07-11 | 1987-07-07 | Ionics, Incorporated | Renaturing reversibly denatured polypeptides and proteins by electrodialysis of solutions thereof in denaturants |
US5039607A (en) | 1988-05-17 | 1991-08-13 | Syntex (U.S.A.) Inc. | Method for immunochromatographic analysis |
US5153312A (en) | 1990-09-28 | 1992-10-06 | American Cyanamid Company | Oligosaccharide conjugate vaccines |
EP0625910B1 (en) | 1992-02-11 | 2003-07-23 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Dual carrier immunogenic construct |
US5425946A (en) | 1992-08-31 | 1995-06-20 | North American Vaccine, Inc. | Vaccines against group C Neisseria meningitidis |
US5849301A (en) | 1993-09-22 | 1998-12-15 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Producing immunogenic constructs using soluable carbohydrates activated via organic cyanylating reagents |
CA2171942C (en) | 1993-09-22 | 2010-12-14 | Andrew Lees | Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs |
US5747663A (en) | 1994-02-07 | 1998-05-05 | Qiagen Gmbh | Process for the depletion or removal of endotoxins |
WO1996017941A2 (en) * | 1994-12-07 | 1996-06-13 | Bionebraska, Inc. | Production of c-terminal amidated peptides from recombinant protein constructs |
KR100417183B1 (ko) * | 1995-03-22 | 2004-05-31 | 헨리 엠. 잭슨 파운데이션 포 더 어드벤스먼트 오브 밀리터리 메디신 | 유기시아닐화제로활성화된가용성탄수화물을이용한면역원성구조체제조 |
CA2215933C (en) * | 1995-03-22 | 2009-10-13 | Andrew Lees | Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents |
KR100254840B1 (ko) * | 1995-03-25 | 2000-05-01 | 힌젠 라이문트 | 폴리사카라이드의 활성화 방법, 이 방법으로 제조된 폴리사카라이드 및 이의 용도 |
WO1996040662A2 (en) | 1995-06-07 | 1996-12-19 | Cellpro, Incorporated | Aminooxy-containing linker compounds and their application in conjugates |
US6309646B1 (en) | 1996-05-09 | 2001-10-30 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine | Protein-polysaccharide conjugate vaccines and other immunological reagents prepared using homobifunctional and heterobifunctional vinylsulfones, and processes for preparing the conjugates |
US7094883B1 (en) | 1996-08-02 | 2006-08-22 | The United States Of America As Represented By The Secretary Of The Army | Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein |
US6248334B1 (en) | 1997-01-08 | 2001-06-19 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this process |
US6299881B1 (en) | 1997-03-24 | 2001-10-09 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts |
ATE278418T1 (de) | 1997-04-24 | 2004-10-15 | Jackson H M Found Military Med | Kopplung unmodifizierter proteinen an haloacyl- oder dihaloacyl-derivatisierten polysacchariden zur herstellung von protein-polysaccharide impfstoffen |
CA2320470A1 (en) | 1998-02-05 | 1999-08-12 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Simplified method for removing free protein during preparation of protein-polysaccharide conjugates and vaccines using restricted-access media |
ATE364395T1 (de) | 1998-04-10 | 2007-07-15 | Andrew Lees | Konjugat-impfstoffe zur vorbeugung der zahnkaries |
JP5138844B2 (ja) | 1998-06-12 | 2013-02-06 | ザ・ヘンリー・エム・ジャクソン・ファンデイション・フォー・ジ・アドヴァンスメント・オヴ・ミリタリー・メディシン、インコーポレイテッド | 抗原およびEBVGp350/220の受容体の同時刺激によるB細胞活性化および免疫グロブリン分泌の増強 |
US7250494B2 (en) | 1998-06-15 | 2007-07-31 | Biosynexus Incorporated | Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria |
US6585973B1 (en) | 1998-10-29 | 2003-07-01 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Method for preparing solid phase conjugated vaccine |
DE19859703B4 (de) | 1998-12-23 | 2009-10-29 | Macherey, Nagel Gmbh & Co. Handelsgesellschaft | Verfahren zur Aufreinigung von Nukleinsäuren sowie Anionenaustauscher zur Durchführung dieses Verfahrens |
US6146902A (en) | 1998-12-29 | 2000-11-14 | Aventis Pasteur, Inc. | Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions |
US6214221B1 (en) | 1999-02-22 | 2001-04-10 | Henry B. Kopf | Method and apparatus for purification of biological substances |
DE60043930D1 (de) * | 1999-03-19 | 2010-04-15 | Glaxosmithkline Biolog Sa | Impfstoff gegen kapsulare polysaccharide von streptococcus pneumoniae |
CU22904A1 (es) | 1999-08-30 | 2004-01-23 | Univ De Ottawa | Oligosacáridos derivados de ribosa- ribitol-fosfato, métodos para prepararlos, inmunógenos que los comprenden y vacunas que comprenden dichos inmunógenos |
US6800728B2 (en) | 2000-03-22 | 2004-10-05 | Solulink Biosciences, Inc. | Hydrazine-based and carbonyl-based bifunctional crosslinking reagents |
CA2406229C (en) | 2000-04-18 | 2010-09-07 | Endobiologics, Incorporated | Anti-sepsis conjugate vaccine |
US20020091242A1 (en) | 2000-10-11 | 2002-07-11 | Michel Bessodes | Acid-sensitive compounds, their preparation and uses |
US20030119004A1 (en) | 2001-12-05 | 2003-06-26 | Wenz H. Michael | Methods for quantitating nucleic acids using coupled ligation and amplification |
US20040052779A1 (en) | 2001-12-21 | 2004-03-18 | Stinson Jeffrey R. | Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria |
US20030224000A1 (en) | 2001-12-21 | 2003-12-04 | Kokai-Kun John Fitzgerald | Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies |
US7482332B2 (en) * | 2002-01-04 | 2009-01-27 | The Board Of Trustees Of The Leland Stanford Junior University | Telomere-encoding synthetic DNA nanocircles, and their use for the elongation of telomere repeats |
JP2005528372A (ja) | 2002-03-26 | 2005-09-22 | バイオシネクサス インコーポレイテッド | 抗菌ポリマー複合体 |
JP2003321432A (ja) * | 2002-05-07 | 2003-11-11 | Nippon Soda Co Ltd | シアノ化合物の製造方法 |
AU2003230406A1 (en) | 2002-05-15 | 2003-12-02 | Zyomyx, Inc. | Immobilization of glycoproteins |
JP2006507288A (ja) | 2002-10-30 | 2006-03-02 | フュトリックス・アクチェンゲゼルシャフト | 神経学的な疾患の処置におけるハッショウマメ種の粉末およびそのエキスを含有する医薬組成物、並びにその使用法 |
CA2524031C (en) | 2003-05-20 | 2015-07-07 | Interlego Ag | Method and system for manipulating a digital representation of a three-dimensional object |
JP4993465B2 (ja) | 2003-12-04 | 2012-08-08 | ユニバーシティ オブ ユタ リサーチ ファウンデーション | 変性された高分子ならびにその製造方法および使用方法 |
AU2005209303A1 (en) | 2004-01-29 | 2005-08-11 | Biosynexus, Inc. | Use of amino-oxy functional groups in the preparation of vaccines conjugates |
US20130302877A1 (en) | 2004-01-29 | 2013-11-14 | Fina Biosolutions Llc | Differential Functionalization of Polymers with Amino-Oxy Reagents for Diagnostic Assays |
EP1784766B1 (en) | 2004-08-10 | 2013-06-05 | Gemalto SA | Progressive unplugging multi-cards body |
KR101359930B1 (ko) | 2004-09-22 | 2014-02-12 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 스태필로코쿠스에 대한 예방접종에 사용하기 위한 면역원성조성물 |
KR20130135399A (ko) * | 2006-03-17 | 2013-12-10 | 더 거버먼트 오브 더 유나이티드 스테이츠 오브 아메리카 에즈 레프리젠티드 바이 더 세크러테리 오브 더 디파트먼트 오브 헬스 앤드 휴먼 서비시즈 | 복합 다가 면역원성 콘쥬게이트의 제조 방법 |
US20070292404A1 (en) | 2006-03-27 | 2007-12-20 | Biosynexus Incorporated | Antimicrobial polymer conjugates |
EP3260134A1 (en) | 2006-08-07 | 2017-12-27 | President and Fellows of Harvard College | Protein matrix vaccines and methods of making and administering such vaccines |
US8554031B2 (en) | 2009-06-17 | 2013-10-08 | University Of North Carolina At Charlotte | Focusing multimodal optical microprobe devices |
WO2011053971A2 (en) | 2009-11-02 | 2011-05-05 | Fina Biosolutions, Llc | Method for enhancing the sensitivity of antibody based assays |
WO2011084705A2 (en) * | 2009-12-17 | 2011-07-14 | Fina Biosolutions, Llc | Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines |
DK2560738T3 (da) | 2010-04-23 | 2019-08-26 | Serum Inst India Ltd | Simpel fremgangsmåde til samtidig fjernelse af flere urenheder fra dyrkningssupernatanter til ultralave niveauer |
-
2010
- 2010-12-17 WO PCT/US2010/061133 patent/WO2011084705A2/en active Application Filing
- 2010-12-17 JP JP2012544919A patent/JP5892944B2/ja active Active
- 2010-12-17 SG SG10201506165TA patent/SG10201506165TA/en unknown
- 2010-12-17 KR KR1020147021710A patent/KR101635795B1/ko active IP Right Grant
- 2010-12-17 ES ES10842660T patent/ES2913180T3/es active Active
- 2010-12-17 EP EP10842660.2A patent/EP2513056B1/en active Active
- 2010-12-17 MX MX2012006961A patent/MX2012006961A/es active IP Right Grant
- 2010-12-17 KR KR1020147021711A patent/KR101635630B1/ko active IP Right Grant
- 2010-12-17 US US13/514,356 patent/US9044517B2/en active Active
- 2010-12-17 CA CA2836140A patent/CA2836140C/en active Active
- 2010-12-17 SG SG10201506160VA patent/SG10201506160VA/en unknown
- 2010-12-17 BR BR122022002139-5A patent/BR122022002139B1/pt active IP Right Grant
- 2010-12-17 BR BR122022002136-0A patent/BR122022002136B1/pt active IP Right Grant
- 2010-12-17 SG SG10201506162RA patent/SG10201506162RA/en unknown
- 2010-12-17 BR BR122022002084-4A patent/BR122022002084B1/pt active IP Right Grant
- 2010-12-17 KR KR1020127018406A patent/KR101427862B1/ko active IP Right Grant
- 2010-12-17 CA CA2836154A patent/CA2836154C/en active Active
- 2010-12-17 KR KR1020147007579A patent/KR101605171B1/ko active IP Right Grant
- 2010-12-17 CA CA2784144A patent/CA2784144C/en active Active
- 2010-12-17 SG SG2012044418A patent/SG181750A1/en unknown
- 2010-12-17 DK DK10842660.2T patent/DK2513056T3/da active
- 2010-12-17 CA CA2836153A patent/CA2836153C/en active Active
- 2010-12-17 CN CN201080057516.XA patent/CN102892753B/zh active Active
- 2010-12-17 BR BR112012014882-6A patent/BR112012014882B1/pt active IP Right Grant
-
2012
- 2012-06-12 ZA ZA2012/04279A patent/ZA201204279B/en unknown
-
2014
- 2014-06-24 US US14/312,748 patent/US9248197B2/en active Active
- 2014-06-24 US US14/312,750 patent/US9259480B2/en active Active
- 2014-06-24 US US14/312,757 patent/US9254337B2/en active Active
-
2015
- 2015-03-17 JP JP2015052991A patent/JP5937712B2/ja active Active
- 2015-03-17 JP JP2015052990A patent/JP5916177B2/ja active Active
- 2015-03-17 JP JP2015052989A patent/JP5917741B2/ja active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI1006519A2 (pt) | formulação de anticorpos | |
BRPI1011145A2 (pt) | anticorpo anti-axl | |
DK2200646T3 (da) | RNA-Vacciner | |
IT1400767B1 (it) | Microsistema | |
FI20095433A0 (fi) | Mikroneula | |
FI20095459A0 (fi) | Uusia määritysmenetelmiä | |
DK2513056T3 (da) | Kemiske reagenser til aktivering af polysaccharider i fremstillingen af konjugatvacciner | |
BR112012001837A2 (pt) | uso de fulvestrant | |
BR112012000565A2 (pt) | ensaio de vírus. | |
BRPI0921578A2 (pt) | vacinas unitemporais | |
DK2462108T3 (da) | Fremgangsmåde til fremstilling af pyrazolcarboxylsyreamider | |
BRPI1016203A2 (pt) | diferencial | |
BRPI0908046A2 (pt) | Aparelho aquecedor | |
BRPI0917913A2 (pt) | micro-partículas | |
BRPI1010060A2 (pt) | diferencial | |
BRPI1008248A2 (pt) | conjunto de condicionamento | |
DK2380896T3 (da) | Fremgangsmåde til fremstilling af oligonukleotid | |
DK2251517T3 (da) | Holdeelement | |
FR2946526B1 (fr) | Sterilet | |
FR2945589B1 (fr) | Diffuseur. | |
DE102009039397A8 (de) | Mikrostrukturverdampfer | |
ES1069249Y (es) | Micro esfera de vidrio fotoluminiscente | |
TH115394B (th) | กระบวนการสำหรับการจัดเตรียมของเบนโซนอร์บอร์นีน | |
UA17093S (uk) | Блендер | |
UA17940S (uk) | Блендер |